World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21098
World Ranking
17644
National Ranking
8814

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Albert B. Deisseroth is affiliated with the US Food and Drug Administration in the United States. Their research primarily focuses on the medical and hematological fields, with a particular emphasis on acute myeloid leukemia and related areas.

The main fields of study in Deisseroth's work include Medicine, with more specialized subfields in Hematology, Molecular Biology, Biochemistry, Oncology, and Genetics. This highlights a multidisciplinary approach to understanding blood cancers and their molecular and genetic underpinnings.

The scientific topics frequently addressed in their publications include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Retinoids in leukemia and cellular processes
  • Antioxidant Activity and Oxidative Stress
  • Neutropenia and Cancer Infections
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Deisseroth has co-authored multiple papers with several researchers, with the most frequent collaborators being Kelly J. Norsworthy, Ann T. Farrell, R. Angelo de Claro, Richard Pazdur, and Rajeshwari Sridhara. These collaborations indicate a network of ongoing research partnerships primarily concentrating on oncology and hematology.

Research outputs from Deisseroth can be found in notable publication venues, including:

  • Clinical Cancer Research
  • Leukemia
  • Journal of Clinical Oncology

Three recent papers attributed to Deisseroth cover various important aspects of leukemia research and treatment:

  • Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis (2020), published in Clinical Cancer Research
  • Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis (2020), published in Leukemia
  • Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses (2021), published in Journal of Clinical Oncology

Albert B. Deisseroth has been recognized as a member of the Association of American Physicians, marking a formal acknowledgment within the medical community.

Best Publications

  • Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.

    L B Owen-Schaub;W Zhang;J C Cusack;L S Angelo

  • Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.

    Albert B. Deisseroth;Zhifei Zu;David Claxton;Elie G. Hanania

  • Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts

    M Korbling;D Przepiorka;YO Huh;H Engel

  • Chronic myelogenous leukemia: a concise update

    H. M. Kantarjian;A. Deisseroth;R. Kurzrock;Z. Estrov

  • Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

    John S. Gottdiener;Frederick R. Appelbaum;Victor J. Ferrans;Albert Deisseroth

  • CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

    S. Giralt;J. Hester;Yang O Huh;Cheryl F Hirsch-Ginsberg

  • Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

    Martin Korbling;Yang O Huh;A. Durett;N. Mirza

  • Considerations in the development of circulating tumor cell technology for clinical use

    David R Parkinson;Nicholas Dracopoli;Brenda Gumbs Petty;Carolyn Compton

  • Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma

    Frederick R. Appelbaum;Geoffrey P. Herzig;John L. Ziegler;Robert G. Graw

  • A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter.

    S. H. Sims;Ying Cha;M. F. Romine;Pei-Qing Gao

  • Localization of the human α-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay

    Albert Deisseroth;Arthur Nienhuis;Patricia Turner;Ramon Velez

  • Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions

    Daniel G. Wright;Kathleen J. Robichaud;Philip A. Pizzo;Albert B. Deisseroth

  • Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

    Philip A Pizzo;Kay J Robichaud;Fred A Gill;Frank G Witebsky

  • p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation

    Wei Zhang;Luigi Grasso;Luigi Grasso;Craig D. McClain;Anne M. Gambel

  • U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

    Thomas Herndon;Albert B Deisseroth;Edvardas Kaminskas;Robert C Kane

  • Scleroderma, Sjögren-like Syndrome, and Chronic Graft-Versus-Host Disease

    Thomas J. Lawley;Gary L. Peck;Haralampos M. Moutsopoulos;Alois A. Gratwohl

  • Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

    Gabriel N. Hortobagyi;Aman U Buzdar;Richard L. Theriault;Vicente Valero

  • Expression of unusual immunophenotype combinations in acute myelogenous leukemia.

    Christopher L. Reading;Elihu H. Estey;Yang O. Huh;David F. Claxton

  • Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

    P.B McGlave;P De Fabritiis;A Deisseroth;J Goldman

  • Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor.

    C. F. LeMaistre;C. Meneghetti;M. Rosenblum;J. Reuben

Frequent Co-Authors

Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
Donna Przepiorka
Donna Przepiorka US Food and Drug Administration
wei zhang
wei zhang Wake Forest University
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Steven M. Kornblau
Steven M. Kornblau The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking alternative or supplementary careers, there are several flexible online degree options. Fields such as pharmacy, health information, medical billing, and nursing offer diverse opportunities and can be pursued virtually from anywhere in the U.S.

Those considering pharmaceutical careers may explore online pharmd programs to earn a doctorate without leaving their job or relocating. Similarly, health information management professionals are in demand to oversee patient data, and pursuing an online mhi can open doors in this growing field.

If you’re looking for a shorter, skills-focused route, the average cost of medical billing and coding program is often much lower than traditional 4-year degrees, making it an accessible entry into healthcare administration.

Aspiring advanced practice nurses can also benefit from cheap np programs, which allow working nurses to upgrade their qualifications online without significant financial burden. These pathways let you tailor your medical career to your interests, schedule, and budget.

Best Scientists Citing Albert B. Deisseroth

Trending Scientists

Recently Published Articles